Insider Transactions in Q3 2017 at Medtronic PLC (MDT)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2017
|
Omar Ishrak Executive Chairman |
SELL
Open market or private sale
|
Direct |
140,407
-21.0%
|
$11,372,967
$81.63 P/Share
|
|
Sep 15
2017
|
Omar Ishrak Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+13.01%
|
$3,800,000
$38.81 P/Share
|
|
Aug 25
2017
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+1.79%
|
$52,520
$52.84 P/Share
|
|
Aug 23
2017
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Indirect |
12,195
+50.0%
|
-
|
|
Aug 23
2017
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Direct |
12,195
-2.1%
|
-
|
|
Aug 01
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Payment of exercise price or tax liability
|
Direct |
11,358
-7.48%
|
$942,714
$83.52 P/Share
|
|
Jul 31
2017
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
9,131
+13.13%
|
-
|
|
Jul 31
2017
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
16,276
+9.42%
|
-
|
|
Jul 31
2017
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,734
+12.31%
|
-
|
|
Jul 31
2017
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
9,528
+12.7%
|
-
|
|
Jul 31
2017
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,497
+15.87%
|
-
|
|
Jul 31
2017
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,925
+16.07%
|
-
|
|
Jul 31
2017
|
Bryan C Hanson EVP, President, MITG |
BUY
Grant, award, or other acquisition
|
Direct |
14,490
+8.71%
|
$1,202,670
$83.97 P/Share
|
|
Jul 31
2017
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,910
+16.57%
|
-
|
|
Jul 31
2017
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
53,591
+8.45%
|
-
|
|
Jul 31
2017
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,322
+8.31%
|
-
|
|
Jul 28
2017
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,872
-6.75%
|
$325,248
$84.29 P/Share
|
|
Jul 28
2017
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,094
-9.59%
|
$427,896
$84.29 P/Share
|
|
Jul 28
2017
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
28,522
-5.13%
|
$2,395,848
$84.29 P/Share
|
|
Jul 28
2017
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-0.64%
|
$27,720
$84.29 P/Share
|
|
Jul 28
2017
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,532
-7.77%
|
$296,688
$84.29 P/Share
|
|
Jul 28
2017
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,621
-4.27%
|
$388,164
$84.29 P/Share
|
|
Jul 28
2017
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
3,914
-6.54%
|
$328,776
$84.29 P/Share
|
|
Jul 28
2017
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
7,270
-4.93%
|
$610,680
$84.29 P/Share
|
|
Jul 17
2017
|
Bryan C Hanson EVP, President, MITG |
SELL
Open market or private sale
|
Direct |
12,000
-8.06%
|
$1,056,000
$88.57 P/Share
|
|
Jul 10
2017
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,010
+2.13%
|
$52,520
$52.84 P/Share
|